Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

mPulse Mobile Adds Brendan Miller as Chief Commercial Officer and Reva Sheehan as Government Programs Strategic Market Executive


mPulse Mobile Chief Commercial Officer, Brendan Miller, and Government Programs Strategic Market Executive, Reva Sheehan

Chief Commercial Officer, Brendan Miller, and Government Programs Strategic Market Executive, Reva Sheehan

Digital health is transforming care delivery, which is the future of healthcare. We continue to invest in solutions that focus on engaging every healthcare consumer as part of this new system of healthcare, with a special focus on health equity and engaging historically underserved populations

mPulse Mobile, the leader in Conversational AI for healthcare, today announced Brendan Miller as Chief Commercial Officer and Reva Sheehan as Government Programs Strategic Market Executive.

Miller’s leadership position in the rapidly growing organization includes teams responsible for sales, partnerships, sales enablement, and marketing, driving toward meeting strategic business initiatives and proactively addressing health plan, health system, business partner, and government needs. With more than two decades of experience transforming healthcare delivery and scaling start-up to mature healthcare companies, most recently on the executive leadership team at Amwell, Miller is tasked with executing mPulse’s growth strategy and evolving go-to-market channels.

“Our long-term relationships with enterprise customers and pushing ourselves to innovate to meet the needs of incoming customers has been key to our growth, and we are eager to build on those relationships,” said mPulse Chief Executive Officer, Chris Nicholson. “Digital health is transforming care delivery, which is the future of healthcare. We continue to invest in solutions that focus on engaging every healthcare consumer as part of this new system of healthcare, with a special focus on health equity and engaging historically underserved populations. In this new era, we’re confident Brendan’s proven record of leading companies to growth and his deep healthcare experience will be a major asset to our organization.”

In addition to Amwell, Miller served in leadership roles for MultiPlan, HealthMine, Wellness Corporate Solutions-LabCorp, and America’s Health Insurance Plans.

Sheehan is an experienced government programs subject matter expert with more than 15 years of industry experience ranging from long-term care and compound pharmacy management to health plan quality and operations, most recently leading Medicare 5-Star Quality initiatives at Priority Health. She is tasked with enhancing mPulse’s support of government plans through technology, relationships, and subject matter expertise.

“We have been so excited about our partnerships with Medicare and Medicaid plans throughout the country, as well as the important impact we have helped make on those key populations,” said Nicholson. “Reva’s experience, expertise in government plans, and passion for member experience is a perfect fit for our organization and will help us continue to build solutions for this segment.”

About mPulse Mobile:

mPulse Mobile, the leader in Conversational AI solutions for the healthcare industry, drives improved health outcomes and business efficiencies by engaging individuals with tailored and meaningful dialogue. mPulse Mobile combines behavioral science, analytics and industry expertise that helps healthcare organizations activate their consumers to adopt healthy behaviors. With over a decade of experience, 100+ healthcare customers and more than 300 million conversations annually, mPulse Mobile has the data, the expertise and the solutions to drive healthy behavior change.

Share article on social media or email:

Emanate Health Announces New Class of Family Medicine Residency Program Physicians


Emanate Health Family Medicine Residency Program Physicians

“These residents will be challenged and empowered to quickly diagnose and treat patients of all ages and ethnicities possessing various pre-existing conditions against the backdrop of a global pandemic.”

Eight new residents begin their three-year journey to become full-fledged doctors

Emanate Health, the largest health care system located in the San Gabriel Valley, today announced its new class of Family Medicine Residency Program physicians. They will treat patients during the next three years at Emanate Health hospitals and local community clinics to complete their formal medical education.

“We’re always excited to welcome a new class of physicians to the Family Medicine Residency Program who bring high levels of energy and enthusiasm to treating our patients on their road to becoming full-fledged doctors,” said Dr. Maili Velez-Dalla Tor, M.D., FAAFP, Director, Emanate Health Family Medicine Residency Program.

During the next three years, the eight new residents will learn about the many intricacies of family medicine care treating diverse patients. They will also participate in a series of rotations in specialty care areas including Cardiology, Neurology and Stroke, Orthopedics, Pediatrics, and Obstetrics and Gynecology to augment their growing medical knowledge.

“These residents will be challenged and empowered to quickly diagnose and treat patients of all ages and ethnicities possessing various pre-existing conditions against the backdrop of a global pandemic,” said Dr. Velez-Dalla Tor. “The complexities behind these clinical challenges will only help to make them better doctors.”        

Residents will spend much of their day seeing patients at Emanate Health Queen of the Valley Hospital in West Covina and at East Valley Community Health Centers in Covina and West Covina, with other training at Emanate Health Inter-Community Hospital in Covina, and Emanate Health Foothill Presbyterian Hospital in Glendora.    

The eight new Emanate Health Family Medicine Residency Program doctors (with their medical schools) include:

  •     Vivian Buhler, MD, University of California, San Francisco School of Medicine
  •     Phoebe Bui, DO, Western University of Health Sciences, Pomona, CA
  •     Salil Chopra, MD, University of California, Riverside School of Medicine
  •     Felicia Cummings, MD, University of Arkansas for Medical Science College of Medicine
  •     Justin D’Agostino, DO, Western University of Health Sciences, Pomona, CA
  •     Nadine Grace-Abraham, MD, Ross University of Medicine, Bridgetown, Barbados
  •     Habib Haidary, MD, American University of the Caribbean School of Medicine, Cupecoy, Sint Maarten.
  •     Angela Lowe, MD, Ross University of Medicine, Bridgetown, Barbados

The Emanate Health Family Medicine Residency Program is an innovative residency program that encourages residents to learn, collaborate and change the way we look at family medicine. The program is affiliated with the Keck School of Medicine of USC and its Department of Family Medicine. We believe that our residents are the future—a generation of physicians possessing great courage, work ethic and joy at the prospect of transforming rather than adapting to the current world of medicine.

###

About Emanate Health

Emanate Health is the largest nonprofit health care provider serving the one million residents of the San Gabriel Valley in California. The system provides specialized care in Behavioral Health, Cancer, Cardiovascular, Emergency, Neuroscience and Stroke, Orthopedics, Sports Medicine, and Women’s Health. Its family of hospitals and hospice include Emanate Health Inter-Community in Covina, Emanate Health Queen of the Valley in West Covina, Emanate Health Foothill Presbyterian in Glendora, Emanate Health Hospice and Home Care in West Covina, as well as other clinics throughout the region. Year after year the health care system has been voted “Best Hospital” and “Best Place to Work” and providers are consistently among the “Top Doctors” in Los Angeles County and hospitals are graded A for Patient Safety by The Leapfrog Group. Visit emanatehealth.org, our Newsroom and connect with us on LinkedIn │Twitter │ Instagram │ Facebook.

Share article on social media or email:

TruBlue Total House Care® and Right at Home® Team Up to Provide Complete In-Home Solutions for Seniors


Sean Fitzgerald

By partnering with Right at Home, we can ensure our clients find in-home care as their needs change. We can also help Right at Home’s clients with needed home modifications and ongoing repairs and maintenance to ensure the home environment remains safe. – Sean Fitzgerald

TruBlue Total House Care, the unique full-service home maintenance franchise, and Right at Home, a leading in-home care provider, are pleased to announce a new and innovative Preferred Provider Agreement between the two companies. With this agreement, TruBlue will be a preferred house care provider for Right at Home, and Right at Home will be a preferred in-home care provider for TruBlue.

TruBlue is a full-service home maintenance company that specializes in working with seniors and families by offering services inside and outside the home, including senior home safety services and modifications, fall prevention, handyman repairs, cleaning services, yard work, seasonal services, and minor home renovations, both through individual services and through their senior-friendly monthly House Care Plus program.

Right at Home is a leader in the in-home senior care industry with more than 600 franchise locations domestically and internationally. Their trained, professional caregivers provide quality in-home care for seniors and adults with disabilities who need some assistance to maintain their independence. Right at Home operates through independently owned and operated home care franchisees.

“Aging in place starts with the home,” TruBlue President Sean Fitzgerald said. “Our goal is to help seniors age worry-free in their own homes and provide peace of mind to their families. Right at Home has done a terrific job caring for seniors and adults with disabilities. By partnering with Right at Home, we can ensure our clients find in-home care as their needs change. We can also help Right at Home’s clients with needed home modifications and ongoing repairs and maintenance to ensure the home environment remains safe. It’s an exciting partnership that truly provides the missing link for longer and more effective ‘aging in place’ living.”

As part of being a preferred provider, TruBlue franchisees will be offering expanded inside and outside senior home safety assessments and providing discounts for services for Right at Home’s clients. Fitzgerald added, “Thanks to Right at Home for being so innovative with this vital collaboration, a safe and properly maintained home is now within the reach of more clients and viewed as a key component of their senior care equation.”

“We identified that one of the biggest challenges to helping seniors age in place is making sure that the home environment is safe,” said Brian Petranick, Right at Home President and CEO. “By partnering with TruBlue, we have a trusted partner we can rely on to provide senior home safety assessments, home modifications, fall prevention, and ongoing home maintenance and repairs. Right at Home and TruBlue both have the goal of providing services that give seniors the ability to age safely and comfortably at home for many enjoyable years, so this partnership provides real solutions for families.”

Older Americans are striving to age in place, with nine out of 10 stating their intent on staying in their home, as reported by the National Council on Aging. TruBlue and Right at Home are poised to make a collaborative impact as people look to stay in their homes longer—especially during the COVID-19 pandemic.

“Supporting a large home care organization like Right at Home means we need to grow rapidly and in multiple markets around the country,” Fitzgerald said. “We now need to find quality franchisees across the U.S. so we can support more of the Right at Home territories and their clients throughout the country.”

Share article on social media or email:

Women’s Excellence Supports Breast Cancer Awareness Month with Convenient Mammogram Screenings and Educational Resources


News Image

About 1 in 8 women in the United States today will get breast cancer at some point during their lifetime. Throughout October, Breast Cancer Awareness Month, Women’s Excellence is calling attention to the important of awareness and early detection of this disease.

Dr. Jonathan Zaidan, MD, FACOG, President of Women’s Excellence, opened a dedicated mammography center within his Ob/Gyn practice to make mammogram screenings more convenient for women.

“The good news is that most women can survive breast cancer if it is found and treated early,” says Zaidan. “A mammogram is a great test to identify abnormalities within the breast tissue that could be cancerous. Unfortunately, one of the biggest problem’s women face when it comes to their healthcare are their busy lives, and, before you know it, 5 years have gone by since you have had your last mammogram. We know that it is hard to get time off work, and it can be inconvenient and stressful to go to unfamiliar hospitals or imaging centers to get your tests done. This is the exact reason why we began offering screening mammograms in our office. Our goal is to make healthcare a priority for women by making these services, such as mammograms, easy and convenient.”

Women’s Excellence has earned ACR accreditation for mammography services. The American College of Radiology (ACR) awards the ACR gold seal of accreditation only to facilities meeting ACR Practice Guidelines and Technical Standards after a peer-review evaluation by board-certified physicians and medical physicists who are experts in the field. Image quality, personnel qualifications, adequacy of facility equipment, quality control procedures, and quality assurance programs are assessed.

One important way that women can stay up to date with their health and wellness is through routine doctor’s visits. Women’s Excellence is encouraging women to get their yearly well-woman exam (annual exam), and depending on your age, a mammogram screening.

“Your annual exam appointment is so important to your overall health. At this appointment, we can identify any new problems you are facing and advise you on the ways you can keep yourself healthy, including routine mammogram screenings,” says Zaidan. “It is our priority to educate the women in our community on the benefits of mammography screening and other cancer prevent tools, like genetic testing, so they can make the best decision for their well-being.”

In addition, Women’s Excellence is invested in patient education. The team at Women’s Excellence provides information and resources during the month of October to increase awareness of breast cancer and the actions women can take to detect breast cancer early. For more information, visit http://www.WomensExcellence.com/blog and Women’s Excellence social media websites.

To schedule an in-office appointment or a telemedicine consultation, visit  http://www.WomensExcellence.com. Online Patient Support Specialists are available Monday through Friday from 8am-5pm to assist new, current, and prospective patients. The chat is located at the bottom right corner of your computer or mobile device screen at http://www.WomensExcellence.com. During offline hours, all chats sent will be messaged directly to a Women’s Excellence team member. Offline messages will receive a response within 24 hours. Messages received during the weekend will be answered the next business week. Appointments can also be made at (248) 693-0543.

About Women’s Excellence

Women’s Excellence is the most comprehensive obstetric and gynecologic office in Michigan. Additionally, they specialize in menopause, weight control, bladder control, endometriosis, robotic surgery, oncology, and midwifery services. Women’s Excellence is committed to staying at the forefront of innovation with cutting edge technologies utilizing robotic surgery and minimally invasive surgical options when possible. The knowledgeable, compassionate physicians and healthcare providers of Women’s Excellence focus on patient-centered processes to deliver the highest quality of care. They are affiliated with most insurances. They offer seamless medical record access via a state-of-the-art patient portal and use the latest technology for record keeping and sharing, making the patient experience easier and more efficient. Women’s Excellence is taking new patients and is conveniently located throughout southeastern Michigan in Clarkston, Lake Orion, Lapeer, Rochester, Royal Oak, and West Bloomfield. Women’s Excellence is also a proud partner of Detroit’s longstanding radio network, WJR 760AM, providing expert women’s health news and information. For more information, visit http://www.WomensExcellence.com.

Share article on social media or email:

International Craft Beverage Manufacturer Good Herb Soda Wins NZ Inspire + Artisan Award with the Backing of Industry Leader True Terpenes


“We are honored to partner with Good Herb Soda, as they share our passion for innovation and drive to provide consumers with a reliable, enjoyable experience every time,” said Chris Campagna, CEO and Founder of True Terpenes.

Good Herb Soda, a New Zealand-based craft soda manufacturer, has won the NZ Inspire+ Artisan Awards in the Craft Beverage category as a result of its innovative use of True Terpenes’ blends in their UnWind and InZone drinks.

The award recognizes a product’s degree of innovation, fit for purpose, visual appeal, taste, price point, and shelf-life and was awarded to Good Herb Soda for its non-alcoholic sparkling herbal beverages. The refreshing fruity blend, UnWind, enhances relaxation, while earthy and ginger flavor, InZone, promotes focus.

“We are honored to receive such a prestigious award that highlights our efforts in beverage innovation,” says Arjun Bhargava, Co-Founder of Good Herb Soda. “Our mission to create healthy non-alcoholic functional drinks that enhance consumers’ experience would not be possible without True Terpenes and the company’s commitment to safety and innovation.”

Terpenes – the organic, aromatic compounds that give botanicals their own unique scent and flavor – enhance the experience of the consumer, promoting energy, focus or relaxation, depending on the terpene used. Good Herb Soda utilizes terpene blends supplied by True Terpenes, the industry-leader in innovation and production of effects-based terpenes and terpenoid blends, to give the sodas a unique flavors and effects.

Good Herb Soda was founded in 2019 with a mission to generate more awareness around the wellness aspect of psychotropics such as cannabis and help consumers curate their experience. Their Natural sparkling terpene sodas are inspired by cannabis strains and recreated using terpenes extracted from natural plants. The company recently become a New Zealand FernMark Licensee. The FernMark Licence Programme is a Government initiative designed to protect and promote New Zealand products to the world.

“We are committed to creating great tasting effects-based drinks for consumers, while maintaining the highest quality and safety standards throughout the industry,” says Arjun Narayanan, Co-Founder of Good Herb Soda. “True Terpenes has set the standard of excellence in their industry, which was integral to our decision in partnering with the company,”

True Terpenes was the first company in the industry to receive GMP/ISO/FSSC certification, which ensures the highest level of quality and safety for its products. The company continues to expand and reach new heights in innovation, while building out a library of botanical and naturally-derived compounds to help companies and consumers around the world experience thousands of flavor profiles.

“Our commitment to creating safe and effective blends is unmatched throughout the industry, as highlighted through our GMP/ISO/FSSC certifications,” says Chris Campagna, CEO and Founder of True Terpenes. “We are honored to partner with Good Herb Soda, as they share our passion for innovation and drive to provide consumers with a reliable, enjoyable experience every time.”

Good Herb Soda is currently available in New Zealand and can be found at major health retailers including IE Produce in Auckland. For more information on purchasing Good Herb Soda visit their website here.

About Good Herb Soda

Good Herb Soda is a beverage manufacturer committed to creating great tasting drinks with effective, reliable effects by utilizing botanical-based terpenes. Their first two effects-based drinks, UnWind and InZone combine a traditional seltzer with botanical-based terpenes in an innovative beverage that tastes great. They are based in Auckland, New Zealand.

About True Terpenes

True Terpenes is the industry-leader in innovation and production of effects-based terpenes and terpenoid blends. The first terpenes company to receive GMP/ISO/FSSC certification, True Terpenes’ ultra-refined botanical terpenes and other aromatic compounds are used by some of the largest beverage, cannabis, cosmetic, food, industrial and pharmaceutical brands for product differentiation. Supported by an expert Scientific Advisory Board, the company is advancing the scientific analysis of terpenes and further studying the “entourage effect,” where the benefits of cannabis can be enhanced when combined with terpenes. By providing a scalable, standardized and high quality solution, True Terpenes is helping companies leverage cannabis flavors.

Disclaimer

Any forward-looking statements included in this document are made as of the date of this document and Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Although management of the Corporation believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct.

Media Contact:

Marino.

Samantha Qualls, Senior Director

TrueTerpenes@marinopr.com

Share article on social media or email:

Blumenthal Nordrehaug Bhowmik De Blouw LLP, File a Class Action Lawsuit Against Sleep Data Services LLC, Alleging Wrongful Termination


Law Offices of Blumenthal Nordrehaug Bhowmik De Blouw LLP

If you would like to know more about the Sleep Data Services LLC lawsuit, please contact Attorney Nicholas J. De Blouw today by calling (800) 568-8020.

The San Diego employment law attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, filed a class action complaint alleging that Sleep Data Services LLC failed to provide their California employees with correct minimum and overtime wages. The Sleep Data Services LLC, class action lawsuit, Case No. 37-2020-00032747-CU-OE-CTL, is currently pending in the San Diego Superior Court of the State of California. A copy of the Complaint can be read here.

The complaint alleges Sleep Data Services LLC committed acts of unfair competition in violation of the California Unfair Competition Law, Cal. Bus. & Prof. Code §§ 17200, et seq. (the “UCL”), by engaging in a company-wide policy and procedure which failed to accurately calculate and record the correct overtime rate for the overtime worked by PLAINTIFF and other CALIFORNIA CLASS Members. As a result of DEFENDANT’s intentional disregard of the obligation to meet this burden, DEFENDANT allegedly failed to properly calculate and/or pay all required compensation for work performed by the members of the CALIFORNIA CLASS and violated the California Labor Code.

Additionally, “DEFENDANT subjected PLAINTIFF to adverse employment action by retaliating against PLAINTIFF.” Allegedly, DEFENDANT failed to properly maintain standard safety measures at the job site and placed employees in a constant risk during the COVID-19 pandemic. As an alleged retaliation, PLAINTIFF’s employment resulted in termination, which is protected against public policy.

If you would like to know more about the Sleep Data Services LLC lawsuit, please contact Attorney Nicholas J. De Blouw today by calling (800) 568-8020.

Blumenthal Nordrehaug Bhowmik De Blouw LLP is an employment law firm with offices located in San Diego, San Francisco, Sacramento, Los Angeles, Riverside and Chicago that dedicates its practice to helping employees, investors and consumers fight back against unfair business practices, including violations of the California Labor Code and Fair Labor Standards Act. If you need help in collecting unpaid overtime wages, unpaid commissions, being wrongfully terminated from work, and other employment law claims, contact one of their attorneys today.

***THIS IS AN ATTORNEY ADVERTISEMENT***

Share article on social media or email:

Mount Sinai Selected to Serve as Capacity Building Center and Center of Excellence as Part of the National Cancer Institute’s New Serological Sciences Network


Researchers from the Icahn School of Medicine at Mount Sinai will receive more than $7.3 million from the National Cancer Institute (NCI) as part of the NCI’s new Serological Sciences Network (SeroNet), one of the largest coordinated national efforts to study immunology and SARS-CoV-2, the virus that causes COVID-19. Mount Sinai was selected as one of only four Capacity Building Centers and one of eight Centers of Excellence as part of this new network.

SeroNet is a major component of NCI’s response to the pandemic and is included in an emergency Congressional appropriation of $306 million to the Institute to develop, validate, improve, and implement serological testing and associated technologies. Through the involvement of more than 25 universities, cancer centers, and laboratories working in partnership with NCI, the National Institute of Allergies and Infectious Diseases and the Frederick National Laboratory, members of SeroNet will work to rapidly deploy serological testing to the American public and to improve our understanding of the immune response to SARS-CoV-2 and mitigate the pathogen’s spread.

“Mount Sinai is at the forefront of cutting-edge research and treatment on COVID-19. Our innovation, creativity, and exceptional staff have found ways to adapt and continue to excel in our drive to translate scientific discovery into practice that will improve public health,” says Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai, and President for Academic Affairs of the Mount Sinai Health System. “We are thrilled to join the National Cancer Institute in this collective endeavor to fight this virus that has affected so many around the world.”

As one of the four SeroNet Capacity Building Centers, Mount Sinai will receive more than $3.46 million from the National Cancer Institute so a multidisciplinary team of Mount Sinai researchers and clinicians can assist with SeroNet’s effort to rapidly deploy and expand SARS-CoV-2 serological testing capacity and practice in the community.

Mount Sinai’s serology testing platforms and operations are uniquely poised to provide a solid translational engine capable of the capacity building SeroNet is committed to accomplishing, said Carlos Cordon-Cardo, MD, PhD, Irene Heinz Given and John LaPorte Given Professor and Chair of Pathology, Molecular and Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai.

“We have a proven track record of accomplishment in implementing, validating, reliably performing, and maintaining high-throughput SARS-CoV-2 serology testing, having developed a highly sensitive and specific antibody test that was one of the very first to receive emergency use authorization by the U.S. Food and Drug Administration and the New York State Department of Health during the early stages of the pandemic,” said Dr. Cordon-Cardo, who will lead Mount Sinai’s capacity-building efforts for SeroNet. “We are extremely grateful to the National Cancer Institute for recognizing our excellence in this arena and for selecting Mount Sinai to assist them in this effort.”

Mount Sinai researchers also received $3.9 million to lead a SeroNet Center of Excellence to study lung cancer patients’ vulnerability to developing severe COVID-19 symptoms and their increased chances of dying from the disease. This is one of eight centers of excellence funded by the NCI as part of the SeroNet initiative. The center of excellence that Mount Sinai is leading will analyze blood samples to determine lung cancer patients’ antibody response when they contract COVID-19 and when they receive a COVD-19 vaccine. Researchers will also study possible changes in lung tumor cells and noncancerous lung cells in lung cancer patients who have COVID-19.

The project will study 1,000 patients with lung cancer and 1,000 patients without lung cancer to determine if there are differences in antibody responses related to age, gender, tobacco history, and race or ethnicity.

“Our overall hypothesis is that lung cancer patients have a weaker antibody response to COVID-19 and that their lung tissue and tumor cells may play a role in their body’s response to infection, which could explain the aggressive course and high fatality rate that we’ve seen,” said Fred R. Hirsch, MD, PhD, Executive Director of the Center for Thoracic Oncology at The Tisch Cancer Institute at Mount Sinai and co-primary investigator of the lung cancer project. “Our U54 Serologic Center will determine whether COVID-19 infection or vaccines will give similar antibody responses in patients with lung cancer compared to patients without lung cancer.”

Dr. Hirsch and Adolfo García-Sastre, PhD, Director of the Global Health and Emerging Pathogens Institute at Mount Sinai, are primary investigators of the lung cancer project and will oversee the center, which also includes researchers from the University of Texas Southwestern, University of Colorado, University of Maryland, and Vanderbilt University.

“The nation’s top researchers in academia, government, and private industry have come together in an unprecedented effort to fight the pandemic,” said Dinah Singer, PhD, deputy director of the National Cancer Institute. “Though SeroNet, we are examining the immune response to the coronavirus to speed delivery of testing, treatments, and vaccine development for COVID-19. What we learn could be applied immediately and will provide invaluable to public health beyond the current pandemic.”

In April 2020, the Mount Sinai antibody test was one of the first to receive emergency use authorization for qualitative use (detection of the presence or absence of antibodies) from both the U.S. Food and Drug Administration and the New York State Department of Health. The Mount Sinai antibody test detects the presence or absence of SARS-CoV-2 antibodies in addition to measuring the titer (level) of antibodies a person has produced. It utilizes not one, but two virus antigens: the full-length spike protein and its receptor-binding domain (RBD), which is correlated with antibody neutralization, as described in a recent paper published in Nature Medicine. The test was used recently in a study by researchers at the Icahn School of Medicine at Mount Sinai that found most people with COVID-19 mount a robust antibody response that is stable for at least three months.

Created by a team of internationally renowned scientists and clinicians at the Icahn School of Medicine at Mount Sinai, the Mount Sinai antibody test is a serological enzyme-linked immunosorbent assay (ELISA) that utilizes both the spike protein and the RBD, which are necessary for viral entry into cells. The toolkit needed to set up the Mount Sinai antibody test has since been shared with hundreds of research laboratories worldwide and has been used by Mount Sinai on more than 68,000 people to determine whether they were exposed to SARS-CoV-2, and to understand their antibody titers both in the initial response to SARS-CoV-2 and over time.

Through SeroNet, Mount Sinai faculty involved in serological testing and immunology research will interact closely, collaborate, and share data, resources, and samples with colleagues at NCI, across the United States and abroad.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

FDAnews Announces — Patents & FDA Regulation of Pharmaceutical Products Webinar Oct. 22, 2020


WCG FDAnews

WCG FDAnews

Patents & FDA Regulation of Pharmaceutical Products

An FDAnews Webinar

Wednesday, Oct. 22, 2020, 1:30 p.m.-3:00 p.m. EDT

https://www.fdanews.com/pharmapatents

Patents and intellectual property (IP) might be the key to success for the drugs a company is developing. How does one talk to one’s patent attorneys and IP specialists about relevant regulatory and compliance mandates? Has the team considered the importance of exclusivity? Are you moving down one of the two major pathways to enable generic and biosimilar drug development?

Through the Patents & FDA Regulation of Pharmaceutical Products webinar on Oct. 22, attendees will get a broad look at how patents and IP relate to drug development and discover how these processes work to provide market exclusivity, keeping competitors at bay.

Patent attorney Joanna Brougher will share different strategies companies can use to develop strong patent portfolios. She’ll also explore how to supplement those patent strategies with FDA exclusivities to protect against competitors.

During this webinar, we’ll cover:


  • How patents and the FDA regulatory process overlap, including during the drug approval process
  • The differences between patent exclusivity and FDA exclusivity, including compliance
  • The various types of FDA exclusivity available and what that means to regulatory specialists
  • Strategies for using exclusivity to build a strong patent portfolio and protect against competitors
  • Reasons drugs manufacturers should understand strategic patent processes
  • Potential weaknesses in patents and how FDA exclusivity can help maintain market protection
  • How orphan drug and pediatric exclusivity can encourage drug development

A strong patent portfolio and a deep understanding of FDA exclusivity can protect drug development from competitors and provide a path toward market success for a product. Ensure the team understands these processes with this essential webinar on patents and IP issues.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally

to learn about our special multisite discount.

Webinar Details:

Patents & FDA Regulation of Pharmaceutical Products

An FDAnews Webinar

Wednesday, Oct. 22, 2020, 1:30 p.m.-3:00 p.m. EDT

https://www.fdanews.com/pharmapatents

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/pharmapatents

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

CORE Higher Education Group Continues Expansion of Pharmacy Services with Appointment of Shannon Staton, Pharm.D, to Senior Director of Pharmacy Solutions


Shannon will play an integral role in the launch of a new CORE product aimed at supporting pharmacy schools and corporate pharmacy partners with their student recruitment efforts.

CORE Higher Education Group announced the promotion of Shannon Staton, Pharm.D, MBA, to Senior Director of Pharmacy Solutions for the EdTech company.

For the past 4 years, Shannon has served as the Director of Education and Clinical Programs at CORE, where she successfully led the development and launch of the READINESS eLearning product to the pharmacy and higher education markets.

In her new role, Shannon will be focused on building and strengthening CORE’s relationships with pharmacy schools and pharmacy employers as CORE continues to expand their portfolio of products across the pharmacy community. Shannon will play an integral role in the launch of a new CORE product aimed at supporting pharmacy schools and corporate pharmacy partners with their student recruitment efforts.

“I am excited to take on this new role at CORE as the Senior Director of Pharmacy Solutions. Over the past few years, I have learned to a deep extent about the needs of pharmacy schools from a digital preparedness, accreditation, assessment, and recruitment perspective. And as a PharmD, it is exciting to have the opportunity to strengthen CORE’s relationships in the pharmacy market,” shared Shannon.

Gregory Cianfarani, CEO of CORE Higher Education Group, said “There is a critical need across the pharmacy industry for solutions that support pharmacy education and the recruitment of prospective pharmacy candidates. Shannon’s combined experience leading similar products to market for higher education, healthcare organizations, and pharmacy B2B companies means she is uniquely positioned to help us magnify CORE’s offerings as we grow into additional business landscapes.”

Shannon also serves as a preceptor for six colleges of pharmacy, as a member of the Rhode Island Pharmacists Association (RIPA), is a diplomat for the Academy of Managed Care Pharmacy (AMCP), and serves on the New Bedford Opioid Task Force.

About CORE Higher Education Group:

Headquartered in Providence, Rhode Island, CORE Higher Education Group is a pharmacist owned and operated education technology company providing software applications that help manage the experiential education process for over 200 colleges and university programs across the US and Canada. Since 2006, CORE has grown to accommodate the experiential education, student competency assessment, co-curricular eLearning, recruiting, and digital portfolio needs for pharmacy education, as well as many other health science disciplines.

Share article on social media or email:

Alitek is a Proud Technology Partner with Mercy Ships as They Launch the World’s Largest NGO Hospital Ship


“Alitek continues to provide guidance on Mercy Ships’ current and future approach to content and information management to improve patient care and operational efficiency,” says Alitek CEO, Mike Brookover.

Alitek is proud to be a technology partner with Mercy Ships as the charity reveals construction of the world’s largest NGO hospital ship, the Global Mercy, which they plan to sail to Africa in late 2021. Mercy Ships, a faith-based global organization powered by charitable donors and volunteers, has been providing world-class surgical care to those in need for more than 40 years, free of charge.

“Alitek continues to provide guidance on Mercy Ships’ current and future approach to content and information management to improve patient care and operational efficiency,” says Alitek CEO, Mike Brookover.

The Global Mercy will deliver a safe and clean environment to various African nations, providing help and resources from some of the most well-trained physicians in the world. Over the vessel’s 50 year expected lifespan, it is estimated that more than 150,000 lives will be changed onboard through surgery alone.

In addition to providing surgeries, the Global Mercy will be outfitted with state-of-the-art training spaces including a simulation lab with virtual and augmented reality, mannequins and other training tools and simulated post-op care space, which allow trainers to simulate local conditions and limitations in order to teach best practices in low-resource environments.

“The Global Mercy will be a true modern marvel— a fully custom-built hospital ship with customized instruments, state-of-the-art technology and highly-trained talent of a modern hospital,” said Rosa Whitaker, president of Mercy Ships. “It also represents a unique call-to-action for anyone called to serve, and it presents the opportunity for people to use their skill set to positively impact global healthcare.”

About Alitek

Alitek is a leader in information based digital transformations. We help organizations improve business outcomes, increase efficiency, and reduce risk, through better management of information. Our experienced team works with you to build a unique strategic plan based on your specific needs, no matter the size of your company. For more information, visit alitek.com

About Mercy Ships

Mercy Ships uses hospital ships to deliver free, world-class healthcare services, capacity building, and sustainable development to those with little access in the developing world. Founded in 1978 by Don and Deyon Stephens, Mercy Ships has worked in more than 55 developing countries, providing services valued at more than $1.7 billion and directly benefitting more than 2.8 million people. Our ships are crewed by volunteers from over 50 nations, with an average of over 2000 volunteers each year. Professionals including surgeons, dentists, nurses, healthcare trainers, teachers, cooks, seamen, engineers, and agriculturalists donate their time and skills. With 16 national offices and an Africa Bureau, Mercy Ships seeks to transform individuals and serve nations one at a time. For more information click on http://www.mercyships.org

Share article on social media or email: